Silencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemia.
Resistance to apoptosis remains a significant problem in drug resistance and treatment failure in malignant disease. NO-aspirin is a novel drug that has efficacy against a number of solid tumours, and can inhibit Wnt signaling, and although we have shown Wnt signaling to be important for acute lymph...
Main Authors: | Adam Cisterne, Rana Baraz, Naveed I Khan, Robert Welschinger, Jordan Basnett, Carina Fung, Helen Rizos, Kenneth F Bradstock, Linda J Bendall |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4111576?pdf=render |
Similar Items
-
mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death.
by: Rana Baraz, et al.
Published: (2014-01-01) -
Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia.
by: Jordan Basnett, et al.
Published: (2017-01-01) -
The tumour necrosis factor receptor family: life or death choices.
by: Jones, E
Published: (2000) -
The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila
by: Jean-Philippe Parvy, et al.
Published: (2019-07-01) -
Making the head: Caspases in life and death
by: Eva Svandova, et al.
Published: (2023-01-01)